February 28, 2015 3:26 PM ET


Company Overview of Cyterix Pharmaceuticals Inc.

Company Overview

Cyterix Pharmaceuticals Inc., a cancer therapeutics company, engages in the discovery and development of small molecule oncology prodrugs. It develops cancer therapeutics based on a proprietary OncoCY prodrug discovery approach. The company was founded in 2010 and is based in San Francisco, California.

1700 Owens Street

Suite 500

San Francisco, CA 94158

United States

Founded in 2010



Key Executives for Cyterix Pharmaceuticals Inc.

Founder, Chief Executive officer, Chief Scientific Officer and Director
Co-Founder and Scientific Advisor
Chief Financial Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
FP1096, Inc. United States
Zengen Inc. United States
Veritas Research Inc. United States
Kalidex Pharmaceuticals, Inc. United States
Kelatron Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cyterix Pharmaceuticals Inc., please visit www.cyterix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.